author-photo

Roel J.W. van Kampen

Maastricht University

19

Papers

435

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Ixazomib, Daratumumab and Low Dose Dexamethasone in Intermediate-Fit Patients with Newly Diagnosed Multiple Myeloma (NDMM); Results of Induction Treatment of the Phase II HOVON 143 Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; Results of the Interim Efficacy Analysis of the Phase II HOVON 143 Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (11)
A real-world study on implementation of new therapeutic options, especially bevacizumab, in a cohort of HER2-negative metastatic breast cancer patients treated with first-line chemotherapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study

2017 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (34)
Functional status decline in older patients with breast and colorectal cancer after cancer treatment

2017
Show All
- Source
- Cite
- Save
Citations (0)
The role of histological subtype in hormone receptor positive metastatic breast cancer : similar survival but different therapeutic approaches

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (9)
Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium

2015 Oncologist
Show All
- Source
- Cite
- Save
Citations (29)
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

2013 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (135)
Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (153)